MMWR: Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis
This report provides provisional CDC guidelines for FDA-approved and unapproved, or off-label, uses of bedaquiline in certain populations who were not included in the clinical trials for the drug. These guidelines are intended for health-care professionals who might use bedaquiline for the treatment...